Denali Therapeutics Inc. (NASDAQ:DNLI) Receives $33.79 Consensus PT from Analysts
Shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) have been assigned a consensus recommendation of “Buy” from the seventeen analysts that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation, fourteen have issued a buy recommendation and two have given a strong buy recommendation […]
Shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) have been assigned a consensus recommendation of “Buy” from the seventeen analysts that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation, fourteen have issued a buy recommendation and two have given a strong buy recommendation […]
